Join MMV's vivax team at ASTMH!
The annual American Society of Tropical Medicine and Hygiene meeting is taking place in Chicago, Illinois, USA from the 18-22 of October.
Emerging Data on How Best to Use Primaquine (PQ) and Tafenoquine (TQ) for the Radical Cure of P. vivax - Sunday, October 22 from 8:00 - 9:45 AM
This symposium, organized by Menzies School of Health Research and MMV, will discuss the emerging data on PQ and TQ and their role in the radical cure of P. vivax.
Schedule:
- 8:10 AM - Trade-off between short term hemolytic risk and long-term benefit of 8-aminoquinoline treatment. Megha Rajasekhar
- 8:25 AM - Is there a way to individualize P. vivax radical cure regimens? Methemoglobin as a marker of antirelapse efficacy. Ihsan Fadilah
- 8:40 - How in vitro and in vivo vivax malaria models can help us understand the outcome of past clinical studies with tafenoquine and design the next set of studies. Brice Campo
- 8:55 AM - The Tafenoquine Roll-out STudy (TRuST): Real-world evidence on feasibility of providing appropriate P. vivax radical cure with tafenoquine or primaquine after G6PD testing in the Brazilian Amazon – final results from a study of over 6,000 patients. Marcus Lacerda
- 9:10 AM - Panel Discussion. Robert J Commons
ARCTIC Poster - Saturday, October 21, from 11:00 AM - 12:45 PM
Title: Research and policy making symbiosis in Thailand: tafenoquine operational feasibility study informing national policy adoption
Poster Number: LB-8450
TRuST Poster - Saturday, October 21, from 11:00 AM - 12:45 PM
Title: Results of the Tafenoquine Rollout STudy in Brazil - a real-world feasibility study of over 6000 patients
Poster Number: LB-8511
Discover what MMV and partners have planned for ASTMH